Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptance of Telemedicine During the COVID-19 Pandemic

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04400448
Recruitment Status : Not yet recruiting
First Posted : May 22, 2020
Last Update Posted : May 28, 2020
Sponsor:
Information provided by (Responsible Party):
Luis Sánchez Guillen, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Brief Summary:

Currently, due to the effects of COVID-19 pandemic, there is an imperative need to change the healthcare model. In this regard, telemedicine has proved very useful in health crises, in which there is a possibility of infection between people, offering remote access to medical care. Telemedicine has been used in many chronic diseases such as asthma and chronic obstructive pulmonary disease, diabetes mellitus, and appears to be well accepted by patients. However, few studies have been conducted in surgical services and in other diseases. Therefore, the aim of this study is to assess the level of acceptance of the patients, in this pandemic situation, to a telemedicine follow-up in different departments.

This is an observational, cross-sectional, multicenter and international study with prospective and retrospective data collection. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ). In addition, all patients will provide an overall satisfaction score for telemedicine on a scale from 1 to 5 (1=lowest; 5=highest satisfaction).


Condition or disease
Covid-19

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 200 participants
Observational Model: Ecologic or Community
Time Perspective: Prospective
Target Follow-Up Duration: 1 Month
Official Title: Acceptance of Telemedicine in Outpatient Clinic Consultations During COVID-19 Pandemic. An International, Cross-sectional Study
Estimated Study Start Date : June 1, 2020
Estimated Primary Completion Date : August 31, 2020
Estimated Study Completion Date : October 31, 2020



Primary Outcome Measures :
  1. Acceptance of telemedicine [ Time Frame: 1 month ]
    Acceptance of telemedicine in consultations during the COVID-19 pandemic. To evaluate patients' acceptance, we used the validated questionnaire Telehealth usability questionnaire (TUQ) as a model. The resulting questionnaire has 10 questions.


Secondary Outcome Measures :
  1. Patient satisfaction [ Time Frame: 1 month ]
    Global satisfaction score on a scale from1 to 5 (1=lowest; 5=highest satisfaction)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients who met the described inclusion criteria will be included in the registry. Participants will be asked to answer an anonymous and voluntary questionnaire by telephone, that will be completed online by the researcher and collaborators through a Google form, aimed to assess the acceptance of the use of telemedicine in consultations during the pandemic.
Criteria

Inclusion Criteria:

  • Patients contacted by telemedicine (phone and/or video call) during the COVID-19 pandemic in outpatient clinics
  • Follow-up of patients with any chronic disease and postoperative patients, preoperative and urgent consultation
  • Age greater than or equal to 18 years

Exclusion Criteria:

  • Patients with cognitive or sensory difficulties or with insufficient comprehension of the language in which the survey is conducted
  • Patients who decline to take part in the telephone survey
Layout table for additonal information
Responsible Party: Luis Sánchez Guillen, Colorectal Surgeon Hospital General Universitario Elche, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
ClinicalTrials.gov Identifier: NCT04400448    
Other Study ID Numbers: TELECOVID
First Posted: May 22, 2020    Key Record Dates
Last Update Posted: May 28, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Luis Sánchez Guillen, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana:
telemedicine
patient acceptance
covid-19